Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride may help prevent hair loss but could cause side effects like sexual dysfunction and psychological issues.

A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Oral finasteride and topical minoxidil can regrow hair, but finasteride may affect fertility.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Higher anxiety levels are linked to sexual dysfunction in women with PCOS.

Testosterone increases muscle mass regardless of DHT conversion blocking.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Pharmacists play a crucial role in personalized therapy, health literacy, and patient care across various health conditions.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Female pattern hair loss does not significantly affect sexual dysfunction.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Adolescent sexual development should focus on positive aspects, including biological, psychological, and contextual factors, and recognize individual differences and the role of pleasure.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Some medications can help increase sexual desire and function in women.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

New genes and pathways are important for testosterone production and male sexual development.